# FDA Inspection 774200 - Medtronic Neuromodulation - May 09, 2012

Source: https://www.keypedia.com/records/fda_inspections/medtronic-neuromodulation/c5ba30f7-5399-4ca7-9039-2b1f6db3723d
Source feed: FDA_Inspections

> FDA Inspection 774200 for Medtronic Neuromodulation on May 09, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 774200
- Company Name: Medtronic Neuromodulation
- Inspection Date: 2012-05-09
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1206222 - 2023-05-05](https://www.keypedia.com/records/fda_inspections/medtronic-neuromodulation/0d67b0cf-c5ee-4657-8149-1b9c652318b7)
- [FDA Inspection 1206222 - 2023-05-05](https://www.keypedia.com/records/fda_inspections/medtronic-neuromodulation/ca41952b-debf-4e58-9a3d-a67b671f3055)
- [FDA Inspection 1187313 - 2022-11-03](https://www.keypedia.com/records/fda_inspections/medtronic-neuromodulation/0826f3ee-c543-4555-ad61-9cede8f200b3)
- [FDA Inspection 1187313 - 2022-11-03](https://www.keypedia.com/records/fda_inspections/medtronic-neuromodulation/a6f03870-6753-4fb1-ada9-63df4eba6325)
- [FDA Inspection 1153966 - 2021-09-09](https://www.keypedia.com/records/fda_inspections/medtronic-neuromodulation/67d9522f-cf08-409f-bdb3-699362a190ad)

Company: https://www.keypedia.com/companies/medtronic-neuromodulation/2a0b2563-ee1c-4a97-a37a-e714223e0f65

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c